Coinbase (COIN) Trades at 'Stratospheric Valuation' Says Jim Chanos - CNBC
Get Alerts COIN Hot Sheet
Rating Summary:
23 Buy, 15 Hold, 6 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Speaking to CNBC on Tuesday, famed short-seller Jim Chanos, who in March said he was betting against Coinbase (NASDAQ: COIN), said the cryptocurrency exchange's services and subscriptions are not growing.
Chanos previously said he expected fees to be compressed as competition in the crypto trading space increased. However, Coinbase CEO Brian Armstrong said to date, they haven't seen fee compression.
Reacting to Armstrong's response, Chanos said the scary thing about the story is that we have not yet seen retail fee compression at Coinbase.
"In fact, their actual dollars per transaction on the retail side was up year-over-year slightly," Chanos told CNBC's Halftime Report. "That compression is still ahead of them."
"The problem, of course, is that volumes have dropped," he added. The short seller referred to the Street revenue estimate being cut from $7.4 billion in March to $3.5 billion now.
"On a revenue basis, even though the stocks been cut in half, so has the revenue estimate," explained Chanos. "This is still an incredibly expensive stock for a company that...let's be clear, is losing a billion dollars a quarter."
"Services and subscriptions was $147 million in the second quarter...that's been flat for four quarters, it's not growing."
Chanos said the issue for the company is that almost all the drivers are under pressure, and the stock trades at a "stratospheric valuation" relative to other broker-dealers such as Robinhood.
"The tangible book value at Coinbase is about $20 per share, but it's going down at the rate of 4 or $5 a share per quarter so Coinbase is going to have a tangible book of about $10 at the end of the year," he claimed.
Coinbase shares are up 0.5% Tuesday.
By Sam Boughedda
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump on Clarity Act: we need Congress to pass it
- Barclays flags an "attractive entry point" in this pharma stock
- China tech giant’s AI bet faces test as cloud growth accelerates
Create E-mail Alert Related Categories
Analyst Comments, Cryptocurrency, Hedge Funds, Hot List, Short SalesRelated Entities
Jim ChanosSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share